Monopar Therapeutics Inc. Increase (Decrease) in Deferred Charges
Monopar Therapeutics Inc. (MNPR) reported Increase (Decrease) in Deferred Charges of $108.43 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2020-11-12
- Monopar Therapeutics Inc. increase (decrease) in deferred charges for the quarter ending 2020-09-30 was $18.91K, a 42.38% increase year-over-year.
- Monopar Therapeutics Inc. increase (decrease) in deferred charges for the quarter ending 2020-06-30 was $71.42K, a 479.62% increase year-over-year.
- Monopar Therapeutics Inc. increase (decrease) in deferred charges for the quarter ending 2020-03-31 was $18.10K, a 30.64% increase year-over-year.
- Monopar Therapeutics Inc. increase (decrease) in deferred charges for the quarter ending 2019-09-30 was $13.28K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month |
|---|---|---|---|
| 2020-09-30 | $18.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $90.33K derived: sum of 2 quarters · filed 2020-11-12 | $108.43K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $71.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $89.52K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $18.10K 10-Q · filed 2020-05-07 | ||
| 2019-09-30 | $13.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $25.60K derived: sum of 2 quarters · filed 2020-11-12 | $39.46K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $12.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $26.18K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $13.86K 10-Q · filed 2020-05-07 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |